Works matching AU Roy, Rupali


Results: 15
    1
    2
    3
    4
    5
    6
    7

    Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 3, p. 497, doi. 10.3109/10428194.2012.722215
    By:
    • Roy, Rupali;
    • Evens, Andrew M.;
    • Patton, David;
    • Gallot, Lillia;
    • Larson, Annette;
    • Rademaker, Alfred;
    • Cilley, Jeffrey;
    • Spies, Stewart;
    • Variakojis, Daina;
    • Gordon, Leo I.;
    • Winter, Jane N.
    Publication type:
    Article
    8
    9

    Household use of iodized salt in rural area.

    Published in:
    Journal of Family Medicine & Primary Care, 2016, v. 5, n. 1, p. 77, doi. 10.4103/2249-4863.184628
    By:
    • Roy, Rupali;
    • Chaturvedi, Manish;
    • Agrawal, Deepika;
    • Ali, Haroon
    Publication type:
    Article
    10
    11
    12
    13
    14
    15